Filter
1346
Filtered Results: 1346
Text search:
co-morbidities
Featured
Recommendations
149
New Publications
236
Language
Document type
No document type
555
Guidelines
310
Studies & Reports
264
Manuals
64
Strategic & Response Plan
64
Fact sheets
46
Situation Updates
16
Training Material
13
Infographics
8
Resource Platforms
4
Brochures
1
Online Courses
1
Countries / Regions
Global
91
India
80
South Africa
43
Kenya
38
Latin America and the Carribbean
38
Western and Central Europe
32
Africa
26
Ethiopia
23
Nigeria
20
Bangladesh
18
Eastern Europe
17
Brazil
17
Uganda
16
Ghana
14
South–East Asia Region
14
Ukraine
12
Rwanda
12
Tanzania
12
Nepal
11
Philippines
10
East and Southern Africa
10
Myanmar / Burma
10
Sierra Leone
9
Syria
9
Malawi
9
Asia
9
West and Central Africa
9
Middle East and North Africa
9
Namibia
9
Zambia
9
Senegal
8
Germany
8
Congo, Democratic Republic of
8
Russia
8
Indonesia
8
Zimbabwe
7
Cameroon
6
Eswatini/ Swaziland
6
Burkina Faso
5
Peru
5
Mozambique
5
Western Pacific Region
5
South Sudan
5
Colombia
4
Chile
4
Eastern Europe and Central Asia
4
United Kingdom
4
Liberia
4
Lesotho
3
Cambodia
3
Vietnam
3
Georgia
3
Angola
3
Pakistan
3
Tajikistan
2
Turkey
2
Benin
2
Togo
2
Laos
2
Guinea
2
Venezuela
2
North America
2
Portugal
2
Bolivia
2
Argentina
2
Egypt
2
Botswana
2
Somalia
2
Ecuador
2
Madagascar
2
North Macedonia
1
Timor Leste/ East Timor
1
Thailand
1
Mexico
1
Gambia
1
Singapore
1
Estonia
1
Afghanistan
1
Burundi
1
USA
1
Haiti
1
Guinea-Bissau
1
Paraguay
1
Gabon
1
Jamaica
1
France
1
Mauritius
1
Spain
1
Algeria
1
Moldova
1
Romania
1
Central African Republic
1
Chad
1
Authors & Publishers
Publication Years
Category
Countries
486
Clinical Guidelines
164
Public Health
95
Women & Child Health
31
Key Resources
16
Capacity Building
9
Pharmacy & Technologies
1
Toolboxes
COVID-19
280
TB
160
HIV
142
Mental Health
122
NCDs
83
NTDs
41
Caregiver
36
AMR
30
Disability
23
Rapid Response
21
Pharmacy
17
Conflict
17
Refugee
14
Planetary Health
10
Health Financing Toolbox
8
Malaria
8
Cholera
7
Ebola & Marburg
7
Global Health Education
5
Natural Hazards
3
Polio
3
Zika
2
Specific Hazards
1
Social Ethics
1
The purpose of this guide is to offer recommendations for improving the implementation of non‑pharmacological public health measures during the COVID-19 response and compliance with these measures by population groups in situations of vulnerability. This requires determining the main barriers to i...
Selection and Use of Essential Medicines 2021
recommended
The 23rd meeting of the WHO Expert Committee on Selection and Use of Essential Medicines was coordinated from Geneva, Switzerland, and held virtually from 21 June to 2 July 2021. The Committee considered 88 applications proposing additions, changes and deletions of medicines, medicine classes and fo...
Informationen für ÄrztInnen und PsychotherapeutInnen. Diese Broschüre informiert über die Situation von Flüchtlingen in Deutschland, darüber, wie sich traumatische Erlebnisse bei Flüchtlingen auf die Gesundheit und das alltägliche Leben auswirken können und wie dies die ärztlichen und psyc...
WHO‘s Global Strategy to Accelerate the Elimination of Cervical Cancer, launched today, outlines three key steps: vaccination, screening and treatment. Successful implementation of all three could reduce more than 40% of new cases of the disease and 5 million related deaths by 2050.
Recency assays use one or more biomarkers to identify whether HIV infection in a person is recent (usually within a year or less) or longstanding. Recency assays have been used to estimate incidence in representative cross-sectional surveys and in epidemiological studies to better understand the pat...
Event-based surveillance (EBS) is defined as the organized collection, monitoring, assessment and interpretation of mainly unstructured ad hoc information regarding health events or risks, which may represent an acute risk to health. Both indicator-based and event-based surveillance components serve...
The introduction of vaccines for coronavirus disease 2019 (COVID-19) added another measure to the existing set of
recommended preventive measures (wearing a mask in public, keeping a distance from other people and regular handwashing). The roll-out of the vaccines, however, raised concerns that vac...
Regional Tuberculosis Program, Pan American Health Organization (PAHO/WHO)
Chronic kidney disease (CKD) is an important contributor to mortality from noncommunicable diseases. No decrease has been seen for CKD mortality contrary to many other important non-communicable diseases (e.g., cardiovascular disease). The prevalence of CKD and kidney failure are increasing all over...
23 February 2022
A summary of the commitments and targets within the United Nations General Assembly’s 2021 Political Declaration on HIV and AIDS.The United Nations General Assembly’s 2021 Political Declaration on AIDS features bold global commitments and targets for 2025 that are ambitious but...
Supplement to the 2016 consolidated Guidelines on the use of antiretroviral drugs for Treating and Preventing HIV infection
HIV Treatment
SCOPING QUESTION: In adults with established status epilepticus (i.e., seizures persisting after the first-line treatment with benzodiazepines [or benzodiazepines-resistant status epilepticus]), which anti-epileptic medications are associated with cessation of seizures and reduced adverse effects)?
...
Why bold action against inequalities is needed to en AIDS, stop COVID-19 and prepare for future pandemics
Cryptococcal disease is one of the most common opportunistic infections among people living with advanced HIV disease and is a major contributor to severe illness, morbidity, and mortality, particularly in sub-Saharan Africa.
These guidelines update the recommendations that were first released i...
54th directing council; 67th session of the regional Committee of WHO for the Americas
CD54/11, Rev. 1, 2 October 2015, Original: Spanish
(Last Update: July 2022)
May 2020 International Journal of Infectious Diseases 96 DOI: 10.1016/j.ijid.2020.05.003
